Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Clinical trial NCT05741476 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05741476
Sponsor: DBV Technologies
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Allergy, Peanut

Start date: 2023-02-21
Primary completion: 2025-11-06
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.